Sponsor or institution

Clinical trials and research at Australasian Leukaemia and Lymphoma Group

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Combination therapy with Epcoritamab for relapsed aggressive B-cell lymphoma

  This study is testing if adding Epcoritamab to chemotherapy helps people with relapsed aggressive B-cell lymphoma get better before a stem cell transplant and live longer without the disease coming back.

  Recruiting Phase 2 Australasian Leukaemia and Lymphoma Group · Melbourne, Victoria · NCT06287398

• Combining Glofitamab and Pirtobrutinib for Mantle Cell Lymphoma

  This study is testing if combining two drugs, Glofitamab and Pirtobrutinib, can help people with relapsed or hard-to-treat Mantle Cell Lymphoma feel better and possibly achieve complete remission.

  Recruiting at 2 sites Phase 2 Australasian Leukaemia and Lymphoma Group · Parkville, Victoria and 1 other locations · NCT05833763

Quick answers

How many clinical trials run by Australasian Leukaemia and Lymphoma Group are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Australia. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →